Novartis Investigative Site

Bergen op Zoom 4624 VT

0 studies enrolling now · 5 studies all time

What they study most

Acne Vulgaris, Atopic Dermatitis, Chronic Spontaneous Urticaria, Hidradenitis Suppurativa

Studies at this site

• Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) — Completed
• Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab — Stopped early
• Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne — Completed
• A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis — Stopped early
• A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients — Stopped early